Pierre Massion
Faculty Member
Last active: 1/11/2018

Pierre Massion M.D. - Publications

  1. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Zhang H, Liu Q, Zimmerman LJ, Ham AJ, Slebos RJ, Rahman J, Kikuchi T, Massion PP, Carbone DP, Billheimer D, Liebler DC (2011) Mol Cell Proteomics 10(6): M110.006593
    › Primary publication · 21357624 (PubMed) · PMC3108838 (PubMed Central)
  2. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB, Miller YE, Franklin WA, Blot WJ, Carbone DP, Shyr Y, Caprioli RM, Massion PP (2011) Cancer Res 71(8): 3009-17
    › Primary publication · 21487035 (PubMed) · PMC3110721 (PubMed Central)
  3. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ (2011) Proc Natl Acad Sci U S A 108(43): 17761-6
    › Primary publication · 22006338 (PubMed) · PMC3203814 (PubMed Central)
  4. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. Polosukhin VV, Cates JM, Lawson WE, Milstone AP, Matafonov AG, Massion PP, Lee JW, Randell SH, Blackwell TS (2011) J Pathol 224(2): 203-11
    › Primary publication · 21557221 (PubMed) · PMC5901746 (PubMed Central)
  5. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Isbell JM, Deppen S, Putnam JB, Nesbitt JC, Lambright ES, Dawes A, Massion PP, Speroff T, Jones DR, Grogan EL (2011) Ann Thorac Surg 91(1): 227-33; discussion 233
    › Primary publication · 21172518 (PubMed) · PMC3748597 (PubMed Central)
  6. Evolving concepts in lung carcinogenesis. Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, Dubinett SM (2011) Semin Respir Crit Care Med 32(1): 32-43
    › Primary publication · 21500122 (PubMed) · PMC3423907 (PubMed Central)
  7. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A (2011) Cancer Prev Res (Phila) 4(6): 803-17
    › Primary publication · 21636547 (PubMed) · PMC3694393 (PubMed Central)
  8. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, Massion PP, Ocak S, Ware LB, Lee JW, Bowler RP, Kononov AV, Randell SH, Blackwell TS (2011) Am J Respir Crit Care Med 184(3): 317-27
    › Primary publication · 21512171 (PubMed) · PMC3265275 (PubMed Central)
  9. A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer. Su Z, Dias-Santagata D, Duke M, Hutchinson K, Lin YL, Borger DR, Chung CH, Massion PP, Vnencak-Jones CL, Iafrate AJ, Pao W (2011) J Mol Diagn 13(1): 74-84
    › Primary publication · 21227397 (PubMed) · PMC3070558 (PubMed Central)
  10. Advances in proteomic strategies toward the early detection of lung cancer. Hassanein M, Rahman JS, Chaurand P, Massion PP (2011) Proc Am Thorac Soc 8(2): 183-8
    › Primary publication · 21543799 (PubMed) · PMC3131837 (PubMed Central)